IFRX
InflaRx N.V.
Company Overview
| Mkt Cap | $89.62M | Price | $1.27 |
| Volume | 430.86K | Change | -7.97% |
| P/E Ratio | -1.9 | Open | $1.35 |
| Revenue | $165.8K | Prev Close | $1.38 |
| Net Income | $-46.1M | 52W Range | $0.71 - $2.82 |
| Div Yield | N/A | Target | $4.33 |
| Overall | 44 | Value | -- |
| Quality | 28 | Technical | 60 |
No chart data available
Stock Overview
Updated DailyInflaRx N.V. (IFRX) is a leading Healthcare company in the Biotechnology industry, currently trading at $1.27 with a market capitalization of $89.62 million. The stock is in the lower portion of its trading range, demonstrating concerning quality fundamentals with a MarketXLS quality score of 28.
Today's trading session shows IFRX with a volume of 431K shares. The stock opened down 2.17% from yesterday's close of $1.38. Current analyst estimates project earnings of $-0.73 per share for this year, with next year targeting $-0.65.
IFRX demonstrates positive technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for IFRX include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 240.9%. The stock shows neutral valuation metrics based on valuation analysis.
Analysis generated on November 5, 2025 at 10:23 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IFRX | $1.27 | -8.0% | 430.86K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |